Thursday Afternoon, March 2024
I was about to log off for the day when our CRM flagged an order stuck in "pending approval" for eight days. It was a Permobil M300 for a rehab clinic in rural Nebraska. Not a huge line item—$2,150 with the standard accessories. But the customer had already paid a 50% deposit, and nobody had touched it since the sales rep submitted it.
I've been doing quality and compliance reviews for medical device orders for six years now. My team reviews roughly 2,000 unique line items a year across mobility, diagnostic, and patient care categories. In our Q4 2024 audit, we rejected about 4% of first-pass deliveries, mostly because of documentation gaps or spec mismatches. So I know what happens when orders sit too long: people rush, corners get cut, and the first casualty is always quality verification.
When I asked the account manager about the delay, he said the clinic was "just a small account" and not worth the engineering time. He wasn't being malicious about it—that's just how quota-driven sales works. Small order, small commission, small priority.
I didn't push it hard enough. That part still bothers me.
The 4:15 PM Call
Three weeks later, the clinic called. Their Permobil M300 was throwing error codes and nobody could figure out what the indicator lights meant. The clinician on the phone was clearly frustrated. She'd lost the physical manual, the PDF saved on their office computer was for a different M300 model year, and the local distributor's phone number had been disconnected.
I pulled the Permobil M300 manual from our documentation server and found the Permobil error code list. The code they described—two amber blinks and a steady red—pointed to a battery communication fault. I knew from our own service logs that this had shown up on specific M300 serial ranges manufactured in 2023. We'd already updated our in-house testing protocol because of it.
The fix turned out to be a reseating of the battery connector plus a system reset. It took the clinic's maintenance guy about fifteen minutes, with me on the phone the whole time.
Here's the thing: that entire call took me 22 minutes. Nobody needed to approve an escalation. It wasn't a complex problem. But picking up the phone and walking them through it made an impression that no brochure or spec sheet could have bought.
That experience also reminded me of a misconception I see constantly in this industry: evaluating medical devices purely on paper specs. It's tempting to think you can compare the Permobil M300 against a competitor by looking at battery capacity, weight limit, and warranty length, and make the right call. But that misses the messy reality—how error codes are documented, whether the manual version actually matches the serial number, how quickly support teams can access real troubleshooting data. Identical specs on paper produce wildly different outcomes when a clinic needs to get a patient mobile before the weekend.
The Unexpected Follow-Up
About a month later, the same clinic reached out again. This time it wasn't about the wheelchair.
The clinic director asked whether we carried a chemistry analyzer that could handle a small lab volume—roughly 40 samples per day. They were also evaluating medical imaging systems for an X-ray room upgrade, and they asked us to quote both. That was unusual. Most small clinics request quotes one category at a time. A combined RFQ meant they were consolidating their vendor list.
To be fair, our sales rep had warned me about this. He said small clinics sometimes solicit quotes purely to get leverage over their local supplier. I get why people assume that. But when I looked at their request, one detail stood out: they specifically mentioned our "documentation quality" and "the support we got on the M300." They weren't price-shopping. They were testing whether we could handle multiple product lines consistently.
We quoted the chemistry analyzer and the medical imaging system. We lost the imaging system—a competitor with a stronger regional installed base took that one. But we won the chemistry analyzer order, plus a recurring supply contract for their home care program. That contract included helping them figure out what types of incontinence products to stock for their patients. It sounds simple, but it involved comparing absorbency ratings, skin compatibility, reimbursement codes, and packaging sizes across five product families. We put it together in an afternoon.
As of January 2025, that "small account" had generated roughly $184,000 in total revenue. The original wheelchair order was $2,150. The ratio still feels absurd in hindsight.
Small Orders, Real Standards
There's a phrase that circulates in procurement circles:
"The best time to evaluate a vendor is on your first small order."
I used to think that was just clever wordplay. Now I think it's the most practical business advice I've encountered.
With a large order, there's enough revenue at stake that even a mediocre vendor will perform. With a $2,000 order, there's no revenue upside to treating you well. So the vendor's behavior on a small order reveals their actual values. Do they answer the phone when you have a problem? Do they check which manual version matches your serial number? Do they flag a potential quality concern even if it delays the shipment?
We're not perfect at this. I should have escalated the deprioritization issue when I first saw it in March. At the time, I figured it was an internal sales workflow problem and not worth the political capital. Looking back, I should have made more noise. The clinic almost didn't get their wheelchair on time because one rep decided "small" meant "later."
Since that experience, we've changed our quality review criteria. Orders under $5,000 now get the same documentation scrutiny as anything else in the pipeline. We added a first-time buyer checklist, regardless of order size, because first-time buyers are the ones most likely to need post-delivery support. And we now log every troubleshooting call that comes through the service desk—not just the ones tied to an active purchase order.
A note on standards: our quality processes align with ISO 13485:2016 for medical device quality management systems. It's a voluntary standard, not a regulatory requirement, but it's the framework we use for review procedures. And per the FDA's quality system regulation (21 CFR Part 820), manufacturers must establish procedures for receiving, reviewing, and approving device orders. Those procedures apply regardless of order size. Most quality failures in medical supply chains start when someone decides an order is "too small" to deserve the full process.
If you're a small clinic or a solo provider evaluating vendors, pay attention to how they handle your first small order. Not just whether the product ships on time, but whether the documentation is correct, whether the phone gets answered, and whether the person on the other end actually knows the product. That's your best signal for how the next five years will go.
Prices and product configurations referenced here reflect our quotes from March 2024 through January 2025. Specifications and support procedures change. Verify current details with Permobil or your authorized distributor before making purchasing decisions.
